Peptides & Pharmacy Law: What You Can (and Can’t) Do | BPC-157, FDA Categories Explained

Peptides are one of the fastest-growing opportunities in pharmacy but also one of the most confusing. In this Atrium24 webinar, healthcare attorneys Dae Lee (PharmD, JD) and Lucas Morgan (JD) of ‪@buchananingersollrooney9951‬ break down the legal and regulatory realities of peptides, including what pharmacies can do today, what’s considered high risk, and how to prepare your pharmacy the right way. If you’re hearing questions about BPC-157, GLP-1s, or “research peptides”, this is a must-watch. 🔍 What You’ll Learn ✔ What “legal” vs “non-compliant” actually means for pharmacies ✔ The difference between FDA Category 1 vs Category 2 peptides ✔ Why peptides like BPC-157 cannot be compounded today ✔ Risks around research peptides and online sourcing ✔ How State Boards of Pharmacy vs FDA enforcement actually works ✔ What pharmacies should be doing right now to prepare ⏱️ Timestamps 00:00 – Welcome & Why Peptides Are the #1 Topic 03:26 – Current Legal Status of Peptides 04:25 – GLP-1s, FDA Enforcement & Lawsuits Explained 06:08 – Category 1 vs Category 2 (What It Means for You) 08:25 – 503A vs 503B: Who Regulates What 09:20 – Why the Market Is Moving Faster Than the Law 12:01 – State-by-State Enforcement Differences 13:10 – “Illegal” vs “Non-Compliant” Explained 14:14 – Why Category 2 Peptides Should Not Be Compounded 17:06 – Real-World Pharmacy Risk Decisions 18:12 – Will BPC-157 Move to Category 1? 21:05 – What’s Actually Allowed with GLP-1 Compounding 25:16 – Research Peptides & Online Market Risks 27:20 – How to Properly Source APIs (Critical Compliance) 29:15 – Biggest Enforcement Mistakes Pharmacies Make 30:22 – Board of Pharmacy Discipline & PBM Risk 32:23 – Surprise Inspections: What to Do 34:32 – When to Call Legal Counsel 46:08 – Compliance Gap Analysis & Risk Prevention 49:23 – Inspection Readiness (OSHA Binder Strategy) 50:34 – Why Marketing Is a Major Enforcement Target 52:16 – What to Do When Peptides Become Available 53:27 – Why Peptides Are Coming (But Not Overnight) 54:18 – Final Advice for Pharmacy Owners ⚠️ Key Takeaway The opportunity is real but the pharmacies that win will be the ones who understand the rules, risks, and regulatory landscape before acting. 🚀 Ready to Launch Peptides in Your Pharmacy? Don’t guess your way into this market. 👉 Be ready to launch peptides the right way. Talk to Sam about your strategy today: https://atrium24.io/contact/ 👇 About Atrium24 Atrium24 helps independent pharmacies grow through compliance-driven strategies, partnerships, and technology, including access to peptide-ready infrastructure, marketing, and sourcing support. 🔔 Subscribe for More Pharmacy Growth Strategies Stay ahead of what’s next in pharmacy.